Intraductal Papilloma with Benign Pathology on Breast Core Biopsy: To Excise or Not?
Talar Tatarian,Claire Sokas,Miguel Rufail,Melissa Lazar,Sanchi Malhotra,Juan P. Palazzo,Elizabeth Hsu,Theodore Tsangaris,Adam C. Berger
DOI: https://doi.org/10.1245/s10434-016-5182-7
IF: 4.339
2016-03-09
Annals of Surgical Oncology
Abstract:BackgroundThe management of intraductal papillomas on core biopsy continues to be controversial. Papillomas with atypia are typically excised. However, it is unclear whether surgical excision is warranted for benign lesions.MethodsA retrospective review of our institution’s pathology and radiology databases from January 2009 through May 2014 identified 119 patients with a diagnosis of benign papilloma without atypia on core biopsy. We determined the rate of carcinoma identification on surgical excision.ResultsThe average patient age was 52.8 years (range 24–84 years). Indication for core biopsy included: abnormal imaging (n = 106), nipple discharge (n = 21), or palpable mass (n = 24). Seventy-five patients underwent surgical excision after core biopsy. Sixteen patients (21.3 %) had atypia in the excision specimen (combination atypical ductal hyperplasia, n = 11; atypical lobular hyperplasia, n = 8; lobular carcinoma-in situ, n = 3), 15 (93.8 %) of which were in the surrounding breast tissue. Two patients (2.7 %) had malignancy (ductal carcinoma-in situ and micropapillary carcinoma-in situ). As a result of surgical findings, 12 % of patients had a change in management. In comparing those with benign findings on surgical pathology and those whose disease was upstaged, there was no statistically significant difference in family history of breast cancer, indication for core biopsy, mammographic findings, or location of papilloma.ConclusionsBenign papillomas diagnosed on core biopsy are rarely upstaged to malignancy on surgical excision. However, at least 21 % of patients may have atypical findings in the surrounding tissue, which could change clinical management. Surgical excision should be considered in patients with benign papillomas.
oncology,surgery